Introduction: Bone conduction implants have been indicated for patients with conductive hearing loss, mixed hearing loss, and even profound unilateral sensorineural hearing loss. With the introduction of Bonebridge®, new transcutaneous implant options emerged. The latest is Osia®, a direct-drive variant or active systems, where the implant directly generates and applies vibration to the bone. Materials and Methods: Retrospective study of two cohorts of patients treated with active bone conduction implants at a single center, one with the Bonebridge® device and the other with Osia®. Outcomes: Fourteen patients were included, seven in each group (n = 14). The Bonebridge® group showed an average hearing gain in tonal intelligibility thresholds of 32.43 ± 21.39 dB and a gain in the average intelligibility threshold (with 50% discrimination) of 26.29 ± 19.10 dB. In the Osia® group, there was a gain in average tonal thresholds of 41.49 ± 14.16 dB and 23.72 ± 6.98 dB in average intelligibility thresholds. Both devices contributed to improvements in patients’ quality of life, as assessed with APHAB in all the variables studied in the test. Both devices offer rehabilitation for hearing loss as an alternative to hearing aids. The Osia® system shows statistically significant (p < 0.05) improvements in mid and high frequencies, but Bonebridge® slightly outperforms in speech understanding at 50%. Differences in average tonal thresholds and quality of life are not statistically significant. Conclusions: While auditory improvement is observed postimplantation, other aspects, such as intelligibility thresholds and quality of life, lack statistical significance. Given the limited experience with Osia® and the small sample size, the choice of the device should be personalized. Although the literature is inconsistent due to small sample sizes and variable approaches, some studies suggest potential advantages of the Osia® system, especially in speech comprehension in different environments and greater hearing gain compared to Bonebridge®.

1.
Amarillo
E
,
Hernández-García
E
,
Herrera
M
,
García Berrocal
JR
,
García Arumí
A
,
Durio
E
, et al
.
Sudden hearing loss: National survey in Spain
.
Acta Otorrinolaringol Esp
.
2016
;
67
(
2
):
59
65
. .
2.
Carnevale
C
,
Til-Pérez
G
,
Arancibia-Tagle
DJ
,
Tomás-Barberán
MD
,
Sarría-Echegaray
PL
.
Hearing outcomes of the active bone conduction system Bonebridge® in conductive or mixed hearing loss
.
Acta Otorrinolaringol Esp
.
2019
;
70
(
2
):
80
8
. .
3.
Pla Gil
I
,
Martínez Beneyto
P
,
Marco Algarra
M
.
Chapter 16 Implantes de conducción de vía ósea
. In:
Ponencia oficial de la Sociedad Española de Otorrinolaringología y patología cérvico-facial
.
CYAN, Proyectos Editoriales, S.A
;
2014
. p.
395
401
.
4.
Moreno-Alarcón
I
,
Belinchón-Diego
AB
.
Resultado funcional y social de los implantes osteointegrados
.
Ediciones Universidad de Salamanca. Rev. ORL
;
2017
.
Vol. 8
; p.
111
7
.
5.
Iñiguez
C
,
Cevo
E
,
Fernández
L
,
Godoy
B
,
Iñiguez
S
.
Detección precoz de pérdida auditiva en niños con factores de riesgo
.
Rev Otorrinolaring Cir Cabeza Cuello
.
2004
;
54
:
99
104
.
6.
Arndt
S
,
Rauch
AK
,
Speck
I
.
Active transcutaneous bone-anchored hearing implant: how I do it
.
Eur Arch Otorhinolaryngol
.
2021
;
278
(
10
):
4119
22
. .
7.
Branemark
R
,
Branemark
PI
,
Rydevik
B
,
Myers
RR
.
Osseointegration in skeletal reconstruction and rehabilitation: a review
.
J Rehabil Res Dev
.
2001
;
38
(
2
):
175
81
.
8.
Clinical Commissioning Policy
.
Bone conducting hearing implants (BCHIs) for hearing loss (all ages)
.
NSH England REF: 16041/P
;
2016
.
9.
Doshi
J
,
Sheehan
P
,
McDermott
AL
.
Bone anchored hearing aids in children: an update
.
Int J Pediatr Otorhinolaryngol
.
2012
;
76
(
5
):
618
22
. .
10.
Lavilla Martín de Valmaseda
MJ
,
Cavalle Garrido
L
,
Huarte Irujo
A
,
Núñez Batalla
F
,
Manrique Rodriguez
M
,
Ramos Macíasde Paula Vernetta
ÁC
, et al
.
Clinical guideline on bone conduction implants
.
Acta Otorrinolaringol Esp
.
2019
;
70
(
2
):
105
11
. .
11.
Tjellström
A
,
Håkansson
B
.
The bone-anchored hearing aid. Design principles, indications, and long-term clinical results
.
Otolaryngol Clin North Am
.
1995
;
28
(
1
):
53
72
. .
12.
Snik
AFM
,
Bosman
AJ
,
Mylanus
EAM
,
Cremers
CWRJ
.
Candidacy for the bone-anchored hearing aid
.
Audiol Neurootol
.
2004
;
9
(
4
):
190
6
. .
13.
Kim
G
,
Ju
HM
,
Lee
SH
,
Kim
HS
,
Kwon
JA
,
Seo
YJ
.
Efficacy of bone-anchored hearing aids in single-sided deafness: a systematic review
.
Otol Neurotol
.
2017
;
38
(
4
):
473
83
. .
14.
Cumpston
E
,
Chen
P
.
Implantable hearing devices
.
2023
.
15.
Florentine
MM
,
Virbalas
J
,
Chan
DK
.
Early surgical and audiologic outcomes of active, transcutaneous, osseointegrated bone-conduction hearing device (Osia 2® system) placement
.
Int J Pediatr Otorhinolaryngol
.
2022
;
156
:
111114
. .
16.
Lazaro
A
,
Artal
R
,
Agreda
B
,
Alfonso
JI
,
Abenia
JM
,
Rubio
R
, et al
.
La implantación de prótesis osteointegradas tipo B.A.H.A. Nuestra experiencia
.
O.R.L Aragon
.
2008
;
11
:
6
10
.
17.
Gasós-Lafuente
AM
,
Lavilla Martín De Valmaseda
MJ
,
Muniesa Del Campo
A
,
Vallés-Varela
H
.
Estudio sobre los implantes percutáneos de conducción ósea: evolución y resultados de 8 años
.
Rev ORL
.
2020
;
12
(
2
):
1
9
. .
18.
Kim
Y
,
Choe
G
,
Oh
H
,
Choi
BY
.
A comparative study of audiological outcomes and compliance between the Osia system and other bone conduction hearing implants
.
Eur Arch Otorhinolaryngol
.
2023
;
280
(
5
):
2217
24
. .
19.
Goycoolea
M
,
Ribalta
G
,
Tocornal
F
,
Levy
R
,
Alarcón
P
,
Bryman
M
, et al
.
Clinical performance of the Osia system, a new active osseointegrated implant system. Results from a prospective clinical investigation
.
Acta Otolaryngol
.
2020
;
140
(
3
):
212
9
. .
20.
Nevoux
J
.
Outcomes of the new Osia system compared to baha attract
.
Presentado en el 7° Congreso Internacional sobre Audición por Conducción Ósea y Tecnologías Relacionadas, 11-14 de diciembre de 2019
.
Miami, EE
:
UU
.
21.
Implantes de Conducción Ósea - BCI 601 - Med-EL
.
Información importante de seguridad
. Available from: www.medel.com/esl/isi-bci-601/.
22.
Crowder
HR
,
Bestourous
DE
,
Reilly
BK
.
Adverse events associated with Bonebridge and Osia bone conduction implant devices
.
Am J Otolaryngol
.
2021
;
42
(
4
):
102968
. .
You do not currently have access to this content.